These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32180729)

  • 21. Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates.
    Morin N; Di Paolo T
    Front Neurol; 2014; 5():144. PubMed ID: 25140165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
    Wu KC; Liou HH; Lee CY; Lin CJ
    Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
    Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
    Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease.
    Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF
    CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.
    Wang R; Wang Y; Qu L; Chen B; Jiang H; Song N; Xie J
    Neurochem Int; 2019 May; 125():127-135. PubMed ID: 30797969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired CBS-H
    Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
    Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.
    Homayoun H; Jackson ME; Moghaddam B
    J Neurophysiol; 2005 Apr; 93(4):1989-2001. PubMed ID: 15590730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
    Tizzano JP; Griffey KI; Schoepp DD
    Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
    Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 2001 Aug; 298(2):453-60. PubMed ID: 11454905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.
    Calon F; Morissette M; Ghribi O; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):127-38. PubMed ID: 11853103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.
    Torres ERS; Akinyeke T; Stagaman K; Duvoisin RM; Meshul CK; Sharpton TJ; Raber J
    Front Behav Neurosci; 2018; 12():140. PubMed ID: 30072879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
    Johnson MP; Barda D; Britton TC; Emkey R; Hornback WJ; Jagdmann GE; McKinzie DL; Nisenbaum ES; Tizzano JP; Schoepp DD
    Psychopharmacology (Berl); 2005 Apr; 179(1):271-83. PubMed ID: 15717213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.